Moreover, as the crosstalk between SIRT1 and autophagy in cerebral ischemia has been increasingly highlighted, clinical and experimental research has been performed to validate the administration of SIRT1 modulators as a potential therapeutic strategy for cerebral I/R injury by targeting the SIRT1-autophagy axis (Table 2). Here, SIRT1 is linked to brain ischemia.